Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Here, the authors report on endosomolytic chloroquine-like lipid nanoparticles for mRNA delivery and genome editing by integrating the chloroquine scaffold into ionizable lipids, demonstrating ...